The biotech industry offers a compelling investment opportunity due to its potential for disruptive innovations and high ...

Now, it has decided to publish a special report on two of GSK's COPD therapies – Breo Ellipta (fluticasone furoate and vilanterol) and Trelegy Ellipta (fluticasone furoate, umeclidinium ...

Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...

As optimism about Beijing's stimulus measures waned, Chinese equities experienced a decline, with the Shanghai Composite ...

The best subscription boxes for men have three things in common: carefully selected products, some level of user customization and a good value for the price. Plus, sometimes you find an ...